Literature DB >> 23232002

Loss to follow-up among infants in a study of isoniazid prophylaxis (P1041) in South Africa.

C A Beneri1, B Zeldow, S Nachman, M Van der Linde, E Pillay, S Dittmer, S Kim, P Jean-Philippe, J Coetzee, R Bobat, E Hawkins, A Violari.   

Abstract

OBJECTIVE: To assess risk factors for loss to follow-up (LFU) from the IMPAACT P1041 study, an isoniazid (INH) prophylaxis study conducted in southern Africa.
DESIGN: Infants in two cohorts, human immunodeficiency virus-infected (HIV+) and HIV-exposed but non-infected (HIV-), were randomized to INH or placebo for 96 weeks. LFU was evaluated at week 96.
RESULTS: Of 1351 infants, 12.9% were LFU (10.4% HIV+, 14.7% HIV-); 65% of the HIV+ cohort was asymptomatic. Among HIV+ infants, large household size (>6 vs. <4 members, P = 0.035) and presence of an elder (≥55 years, P = 0.05) were associated with better retention. Although attenuated in adjusted analysis, these associations held among HIV- infants. Among HIV- infants, having a younger mother increased the risk (P = 0.008) and maternal history of TB reduced the risk of LFU, the latter by nearly 70% (P = 0.048 univariate, 0.09 adjusted). LFU was largely due to inability to contact the participant (58% HIV+, 30% HIV-), and inability to attend the clinic and withdrawal of consent (HIV-).
CONCLUSIONS: Household support was an important factor in participant retention, particularly for the non-HIV-infected cohort, as young maternal age was a risk factor for LFU. Retaining study participants from this mobile population can be challenging and may warrant additional support.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23232002      PMCID: PMC3556820          DOI: 10.5588/ijtld.12.0282

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  12 in total

1.  Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children.

Authors:  Shabir A Madhi; Sharon Nachman; Avy Violari; Soyeon Kim; Mark F Cotton; Raziya Bobat; Patrick Jean-Philippe; George McSherry; Charles Mitchell
Journal:  N Engl J Med       Date:  2011-07-07       Impact factor: 91.245

2.  Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa.

Authors:  Elvin H Geng; David V Glidden; Nneka Emenyonu; Nicolas Musinguzi; Mwebwesa Bosco Bwana; Torsten B Neilands; Winnie Muyindike; Constantin T Yiannoutsos; Steven G Deeks; David R Bangsberg; Jeffrey N Martin
Journal:  Trop Med Int Health       Date:  2010-06       Impact factor: 2.622

3.  Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children.

Authors:  S A Madhi; K Petersen; A Madhi; M Khoosal; K P Klugman
Journal:  Clin Infect Dis       Date:  2000-07-25       Impact factor: 9.079

4.  Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial.

Authors:  Ian Sanne; Catherine Orrell; Matthew P Fox; Francesca Conradie; Prudence Ive; Jennifer Zeinecker; Morna Cornell; Christie Heiberg; Charlotte Ingram; Ravindre Panchia; Mohammed Rassool; René Gonin; Wendy Stevens; Handré Truter; Marjorie Dehlinger; Charles van der Horst; James McIntyre; Robin Wood
Journal:  Lancet       Date:  2010-07-03       Impact factor: 79.321

5.  High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies.

Authors:  A C Hesseling; M F Cotton; T Jennings; A Whitelaw; L F Johnson; B Eley; P Roux; P Godfrey-Faussett; H S Schaaf
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

Review 6.  The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era.

Authors:  B J Marais; R P Gie; H S Schaaf; A C Hesseling; C C Obihara; J J Starke; D A Enarson; P R Donald; N Beyers
Journal:  Int J Tuberc Lung Dis       Date:  2004-04       Impact factor: 2.373

7.  Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa.

Authors:  Candace M Miller; Mpefe Ketlhapile; Heather Rybasack-Smith; Sydney Rosen
Journal:  Trop Med Int Health       Date:  2010-06       Impact factor: 2.622

8.  High rate of loss to clinical follow up among African HIV-infected patients attending a London clinic: a retrospective analysis of a clinical cohort.

Authors:  Sarah M Gerver; Tim R Chadborn; Fowzia Ibrahim; Bela Vatsa; Valerie C Delpech; Philippa J Easterbrook
Journal:  J Int AIDS Soc       Date:  2010-08-04       Impact factor: 5.396

9.  Excellent outcomes among HIV+ children on ART, but unacceptably high pre-ART mortality and losses to follow-up: a cohort study from Cambodia.

Authors:  Marie-Eve Raguenaud; Petros Isaakidis; Rony Zachariah; Vantha Te; Seithabot Soeung; Kazumi Akao; Varun Kumar
Journal:  BMC Pediatr       Date:  2009-08-20       Impact factor: 2.125

Review 10.  Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review.

Authors:  Sydney Rosen; Matthew P Fox; Christopher J Gill
Journal:  PLoS Med       Date:  2007-10-16       Impact factor: 11.069

View more
  2 in total

1.  Source case identification in HIV-exposed infants and tuberculosis diagnosis in an isoniazid prevention study.

Authors:  E R Maritz; G Montepiedra; L Liu; C D Mitchell; S A Madhi; R Bobat; A Violari; A Ogwu; A C Hesseling; M F Cotton
Journal:  Int J Tuberc Lung Dis       Date:  2016-08       Impact factor: 2.373

2.  Time Until Loss to Follow-Up, Incidence, and Predictors Among Adults Taking ART at Public Hospitals in Southern Ethiopia.

Authors:  Samuel Dessu; Molalegn Mesele; Aklilu Habte; Zinabu Dawit
Journal:  HIV AIDS (Auckl)       Date:  2021-02-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.